Can Creatine Support Brain Energy? What Early Alzheimer's Research Shows

Researchers became interested in creatine for Alzheimer's disease because impaired brain bioenergetics is considered a pathological hallmark of the condition — and the brain's creatine system appears to be directly involved in maintaining that energy flux. A 2025 pilot study found that eight weeks of creatine supplementation increased brain total creatine by 11% and was associated with measurable cognitive improvements. The findings are encouraging. They are also early, and the distinction between a promising signal and a proven treatment matters.

Why Researchers Are Looking at Creatine Here

The connection between creatine and brain energy isn't new — but its application to neurodegeneration is. The brain is one of the most energy-demanding organs in the human body, and ATP availability is central to how neurons function, communicate, and survive. When the brain's ability to produce and recycle ATP becomes impaired — as it does in Alzheimer's disease — the phosphocreatine system becomes a logical research target, because that system exists specifically to buffer and regenerate ATP under high energy demand.

That biological rationale is what drew researchers to study creatine in this context. It creates a clear scientific reason to investigate. It does not, by itself, prove that creatine changes the course of the disease. That distinction is the difference between responsible science communication and hype — and it's one Lawrence takes seriously.

The Study: What It Measured and How It Was Designed

The early human study most people are now referencing came out of the University of Kansas Medical Center. In the 2025 pilot paper, researchers evaluated eight weeks of creatine monohydrate supplementation at 20 grams per day in 20 participants with Alzheimer's disease.

The study was designed as a single-arm pilot — built to test feasibility and generate early signals rather than deliver a final clinical verdict. Researchers tracked three things across the intervention: compliance, brain creatine levels, and cognitive outcomes. That design makes the paper useful and worth reading carefully. It also tells you immediately why the results need context.

What the Study Found

The results were encouraging for an early-stage study.

Compliance — Nineteen of twenty participants achieved the target threshold of at least 80% compliance, suggesting the protocol was workable in this population. For a study at this stage, that's a meaningful finding on its own.

Brain creatine levels — Researchers reported that brain total creatine increased by 11% over the study window. That matters because it confirms the intervention reached the brain target — not just the bloodstream. Creatine crossing into the central nervous system in measurable amounts is the prerequisite for any cognitive effect.

Cognitive outcomes — The paper reported improvements in global and fluid cognition composites, along with gains on List Sorting, Oral Reading, and Flanker testing. These findings suggest that increased brain creatine was associated with measurable cognitive changes — enough to justify continued investigation.

What the Study Did Not Prove

Just as important as what the study found is what it did not establish.

The authors themselves described the results as preliminary evidence for future efficacy and mechanism studies. This was a pilot — twenty participants, no control group, no randomization, no placebo arm. Those aren't criticisms of the research team. They're the honest boundaries of what this study was designed to answer, and reading the results within those boundaries is how you stay oriented in early science.

The trial also did not test a combined formula with creatine, vitamin B-12, and taurine. That means creatine is the research anchor in this discussion. B-12 and taurine belong to the broader brain-support conversation for separate, well-supported reasons.

Where B-12 and Taurine Fit — and Why They're Kept Separate Here

B-12 belongs in the brain energy conversation because it is required for central nervous system myelination and healthy red blood cell formation. Without adequate B-12, the neural infrastructure that creatine-fueled ATP is meant to power degrades — slower signaling, impaired neurotransmitter synthesis, compromised oxygen delivery to brain tissue.

Taurine belongs because reviews describe roles in neuromodulation, calcium homeostasis, and mitochondrial function — all relevant to the broader bioenergetics picture that Alzheimer's research is examining.

The cleanest and most credible framing keeps those roles separate rather than collapsing the Alzheimer's creatine findings onto B-12 and taurine as if the evidence were the same for all three. It isn't — and saying so clearly is more useful than overstating it.

That separation makes the story stronger, not weaker. Creatine provides the research-forward brain energy angle. B-12 reinforces the neurological and metabolic foundation. Taurine adds a cellular-balance layer that fits the broader bioenergetics picture. Together they help explain why brain energy is more than a one-ingredient conversation — without erasing the need for better trials, better study design, and a larger evidence base.

The Bigger Picture

This research sits inside a larger framework: brain energy isn't just about one supplement, one study, or one outcome. It's about building the daily conditions — movement, sleep, nutrition, consistent supplementation — that give your brain what it needs to perform and protect itself over time.

Creatine's role in that framework is becoming clearer. What early Alzheimer's research shows is a meaningful signal worth following. What it calls for is continued rigorous science — and in the meantime, a daily habit that supports the brain energy system while that science matures.

Frequently Asked Questions

Does creatine help with Alzheimer's disease? No current evidence supports creatine as a treatment for Alzheimer's disease. A 2025 pilot study found encouraging early signals — including an 11% increase in brain creatine and measurable cognitive improvements — but the study was small, lacked a control group, and was designed to generate hypotheses for future research, not establish clinical efficacy.

Why are researchers studying creatine for brain health? Because impaired brain bioenergetics is a hallmark of Alzheimer's disease, and the phosphocreatine system exists specifically to buffer and regenerate ATP under high energy demand. The biological rationale for investigating creatine in this context is direct and well-grounded in neuroscience.

How much creatine was used in the Alzheimer's pilot study? The University of Kansas Medical Center study used 20 grams per day for eight weeks — a higher dose than the standard 5g daily maintenance dose used in most physical and cognitive performance research. The study was designed to maximize the brain saturation signal in a short pilot window.

What cognitive improvements were observed? The 2025 pilot reported improvements in global and fluid cognition composites, along with gains on List Sorting, Oral Reading, and Flanker testing. The authors described these as preliminary findings consistent with the hypothesis that increased brain creatine supports cognitive function.

Does creatine cross into the brain? Yes. The study confirmed an 11% increase in brain total creatine following supplementation — measurable via neuroimaging. Creatine crosses the blood-brain barrier, though less efficiently than it enters muscle tissue, which is why dose and duration matter.

Where do B-12 and Taurine fit in the Alzheimer's research? They don't appear in the Alzheimer's creatine trials directly. B-12 is supported by separate research on neural myelination, red blood cell formation, and neurotransmitter synthesis. Taurine is supported by research on neuromodulation, calcium homeostasis, and mitochondrial function. Each addresses a distinct layer of brain energy support.

Is creatine safe for older adults? Yes. Creatine monohydrate has a well-established safety record across populations including older adults, with no significant adverse effects observed at standard doses in long-term research. The 2025 pilot specifically studied adults with Alzheimer's disease with a high compliance rate and no reported safety concerns.

See you in the wild!

— Lawrence

Creatine Gummies by Vybrance Labs™ — the first and only creatine gummy formulated for brain clarity, powered with B-12 and Taurine. Third-party tested, vegan, sugar-free, and built for daily cognitive energy. Shop now →

Sources: University of Kansas Medical Center Pilot Study, 2025; Gordji-Nejad et al., Scientific Reports, 2024; Smith-Ryan et al., Nutrients, 2021; International Society of Sports Nutrition Position Stand on Creatine Supplementation.